Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC

R Hass, C Kasper, S Böhm, R Jacobs - Cell Communication and Signaling, 2011 - Springer
The mesenchymal stroma harbors an important population of cells that possess stem cell-
like characteristics including self renewal and differentiation capacities and can be derived …

Breast cancer stem cells: Biology and therapeutic implications

R Butti, VP Gunasekaran, TVS Kumar… - The international journal …, 2019 - Elsevier
Breast cancer remains to be a dreadful disease even with several advancements in
radiation and chemotherapies, owing to the drug resistance and tumor relapse caused by …

Mesenchymal stem cells directly interact with breast cancer cells and promote tumor cell growth in vitro and in vivo

K Mandel, Y Yang, A Schambach, S Glage… - Stem cells and …, 2013 - liebertpub.com
Cellular interactions were investigated between human mesenchymal stem cells (MSC) and
human breast cancer cells. Co-culture of the two cell populations was associated with an …

Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment

R Hass, A Otte - Cell Communication and Signaling, 2012 - Springer
Mesenchymal stem cells (MSC) represent a heterogeneous population exhibiting stem cell-
like properties which are distributed almost ubiquitously among perivascular niches of …

Anti-CD105 antibody eliminates tumor microenvironment cells and enhances anti-GD2 antibody immunotherapy of neuroblastoma with activated natural killer cells

HW Wu, MA Sheard, J Malvar, GE Fernandez… - Clinical Cancer …, 2019 - AACR
Purpose: We determined whether elimination of CD105+ cells in the tumor
microenvironment (TME) with anti-CD105 antibodies enhanced anti-disialoganglioside …

Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer

U De Giorgi, M Mego, E Scarpi, M Giuliano… - Clinical breast …, 2012 - Elsevier
Introduction Lymphocytopenia and circulating tumor cells (CTCs) have been reported as
independent prognostic factors for overall survival (OS) in metastatic breast cancer (MBC) …

[HTML][HTML] Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects

LF Hutchins, I Makhoul, PD Emanuel, A Pennisi… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Tumor-associated carbohydrate antigens (TACAs) support cell survival that could be
interrupted by anti-TACA antibodies. Among TACAs that mediate cell survival signals are the …

[HTML][HTML] GD2 expression in breast cancer

G Orsi, M Barbolini, G Ficarra, G Tazzioli, P Manni… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Breast cancer (BC) is a heterogeneous disease, including different subtypes having diverse
incidence, drug-sensitivity and survival rates. In particular, claudin-low and basal-like BC …

Dielectrophoretic capture and genetic analysis of single neuroblastoma tumor cells

EL Carpenter, JA Rader, J Ruden, EF Rappaport… - Frontiers in …, 2014 - frontiersin.org
Our understanding of the diversity of cells that escape the primary tumor and seed
micrometastases remains rudimentary, and approaches for studying circulating and …

Variable expression of the disialoganglioside GD2 in breast cancer molecular subtypes

R Erber, S Kailayangiri, H Huebner, M Ruebner… - Cancers, 2021 - mdpi.com
Simple Summary GD2 is an antigen that is tumor-specific and can be used as a target for
specific immunotherapies. Since the knowledge about GD2 in breast cancer is limited, we …